Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Eva Hubmann"'
Autor:
Jakob Michael Riedl, Florian Posch, Gerald Prager, Wolfgang Eisterer, Leopold Oehler, Thamer Sliwa, Klaus Wilthoner, Andreas Petzer, Petra Pichler, Eva Hubmann, Thomas Winder, Sonja Burgstaller, Markus Korger, Johannes Andel, Richard Greil, Hans-Joerg Neumann, Martin Pecherstorfer, Kathrin Philipp-Abbrederis, Angela Djanani, Birgit Gruenberger, Friedrich Laengle, Ewald Wöll, Armin Gerger
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 12 (2020)
Background: The pretreatment De Ritis ratio [aspartate transaminase (AST)/alanine transaminase (ALT)] has been shown to be an adverse prognostic marker in various cancer entities. However, its relevance to advanced pancreatic ductal adenocarcinoma (P
Externí odkaz:
https://doaj.org/article/6ae640a6f55e4ed2b9869593c943f051
Autor:
B. Mlineritsch, Catharina Arnold-Schrauf, Johannes Andel, Birgit Gruenberger, Klaus Wilthoner, Robert Trondl, Leopold Oehler, Hans-Joerg Neumann, Thomas Winder, Andreas L. Petzer, Kathrin Philipp-Abbrederis, Wolfgang Eisterer, Armin Gerger, Petra Pichler, Gerald W. Prager, Angela Djanani, Friedrich Laengle, Markus Korger, Martin Pecherstorfer, Sonja Heibl, Eva Hubmann, Ewald Wöll, Thamer Sliwa
Publikováno v:
European journal of cancer (Oxford, England : 1990). 143
Background Pancreatic cancer (PC) ranks among the deadliest malignancies worldwide. In the MPACT study, first-line nab-paclitaxel plus gemcitabine (nab-P/G) demonstrated activity (median overall survival [OS], 8.7 months) and tolerability in patients
Autor:
Leopold Oehler, Johannes Andel, Thamer Sliwa, Klaus Wilthoner, Eva Hubmann, Richard Greil, Petra Pichler, Thomas Winder, Ewald Wöll, Gerald W. Prager, Jakob M. Riedl, Andreas L. Petzer, Hans-Joerg Neumann, Markus Korger, Armin Gerger, Kathrin Philipp-Abbrederis, Wolfgang Eisterer, Martin Pecherstorfer, Friedrich Laengle, Florian Posch, Sonja Burgstaller, Angela Djanani, Birgit Gruenberger
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 12 (2020)
Therapeutic Advances in Medical Oncology
Therapeutic Advances in Medical Oncology
Background: The pretreatment De Ritis ratio [aspartate transaminase (AST)/alanine transaminase (ALT)] has been shown to be an adverse prognostic marker in various cancer entities. However, its relevance to advanced pancreatic ductal adenocarcinoma (P
Publikováno v:
Annals of Hematology. 100:2111-2112
Publikováno v:
Clinical Chemistry and Laboratory Medicine (CCLM). 57:e34-e36
Autor:
Christine Beham-Schmid, Wilma Zinke-Cerwenka, Eva Hubmann, Magnus Björkholm, Nataliya Vytrva, Sabine Hojas, Gerald Hoefler, Elvira Stacher, Anna Porwit, Peter Regitnig
Publikováno v:
Archives of Pathology & Laboratory Medicine. 138:1203-1209
Megakaryocytes are the "hallmark" of Philadelphia chromosome-negative myeloproliferative neoplasms, such as essential thrombocythemia, polycythemia vera, and primary myelofibrosis; their morphology in correlation with Janus kinase 2 (JAK2 V617F) muta
Autor:
Dietmar Geissler, Renate Thalhammer, Dietger Niederwieser, Renate Heinz, Wolfgang Hinterberger, Klaus Lechner, Paul Knöbl, Elisabeth Koller, Ulrich Jaeger, Eva Hubmann, Klaus Geissler, Ingrid Pabinger, Christine Mannhalter, Werner Linkesch, Paul A. Kyrle, Ilse Schwarzinger
Publikováno v:
Scopus-Elsevier
Because of the recommendation to avoid the concomitant administration of growth factors and chemotherapy, there is only limited information on colony-stimulating factor (CSF ) therapy in acute lymphoblastic leukemia (ALL) induction protocols, in whic
Autor:
Felix Keil, Gerhard Leitner, Thomas Bauernhofer, Hans Rabl, Martin Pichler, Martin Uggowitzer, Christoph Tinchon, Angelika Pichler, Kurt Jilek, Eva Hubmann
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::49a63bb8d648e83d05792ccd63ff0919
https://opus.bibliothek.uni-augsburg.de/opus4/frontdoor/index/index/docId/105264
https://opus.bibliothek.uni-augsburg.de/opus4/frontdoor/index/index/docId/105264